DermTech
DermTech
dermtech.com

Locations

United States · San Diego, CA, USA

industry

Biotechnology · Consumer Products · DeepTech · Health

Size

51-200 employees

Stage

Other

founded in

2024

DermTech develops and commercializes qPCR assays for skin samples collected non-invasively using adhesive tape biopsy methods. The Company’s assays can analyze multiple gene targets to assess their level of RNA expression. The Company anticipates providing these assays through a CLIA certified laboratory located in San Diego. The Company will initially offer an assay for pigmented skin lesions sampled using an adhesive tape collection method. The Company has identified gene targets differentially expressed in melanoma samples (British Journal of Dermatology, April 2011). This assay can assess RNA expression consistent with melanoma with very high sensitivity (>95%) and specificity (>70%).

Something looks off?
Open jobs at DermTech
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.